Phase Lib Trial Of Tivantinib In Combination With Carboplatin And Pernetrexed As First-Line Treatment In Patients (Pts) With Advanced Nonsquamous Nsclc Or Malignant Pleural Mesotheliorna (Mpm).
JOURNAL OF CLINICAL ONCOLOGY（2014）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要